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ABSTRACT 
Objectives: Little is known about sex differences in healthy life expectancy among the oldest old, the 
fastest growing segment of the older population. This study examines sex differences in total, healthy 
and unhealthy life expectancy among nonagenarians.  
Methods: Longitudinal data of 884 older adults aged 90 and over participating in the Vitality 90+ 
study (Tampere, Finland) were used, including 2,501 observations (health or death states) from 5 
measurement waves between 2001 and 2014. Using the MSM and ELECT packages in R, multistate 
survival models were performed to estimate the transition probabilities of older adults through the 
different health states and to calculate life expectancies. The analyses were done separately for two 
health indicators (disability and multimorbidity) to see whether patterns were consistent.  
Results: Women had higher total life expectancies than men (about 8 months), but also higher 
unhealthy life expectancies. Men had a higher disability-free life expectancy between the age of 90 
and 95 compared to women. For multimorbidity, no sex differences in healthy life expectancy were 
found.  
Conclusions: This study showed that the male-female health-survival paradox remains at very old 
age. Women aged 90+ live longer than men, and spend more time in poor health. 
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1. Introduction 
The male-female health-survival paradox is well-established in many countries worldwide [1-4]. This 
is the phenomenon that higher life expectancy is accompanied by higher rates of poor health in women 
compared to men. This is seen as a paradox, since poor health is usually associated with lower 
survival. The fact that men die at younger ages than women, despite their better health, has been 
attributed to various biological, behavioral, social and contextual factors [5].  
Despite the large number of studies focused on sex differences in health and mortality, 
relatively little is known about the male-female health-survival paradox at very old age, i.e. people 
aged 90 and over, for several reasons. First, although the oldest old constitute one of the fastest 
growing segments of the older population [6], the increasing number of people in this age group is still 
a quite recent development [7]. Second, population-based studies of older adults rarely include 
sufficient data on people aged 90 and over, to be able to calculate reliable estimates on healthy life 
expectancy. Therefore, little is known about the extent to which sex differences in healthy life 
expectancy continue to exist at very old age.  
The few studies that have been conducted among the oldest old show that men have a higher 
risk of mortality than women in populations aged 85 years and older [8, 9]. These studies also found 
that disability increases the risk of mortality more in men than in women [8, 9]. However, what this 
exactly means for the number of years lived in good and poor health at very old age remains unclear. 
The only longitudinal study that provides detailed insight into healthy life years among people aged 90 
years and older was conducted in Denmark [10]. This study calculated average lifetimes of Danish 
oldest old between 1998 and 2005, and observed between the ages of 92 and 100 an average life time 
of 2.7 years for men and 3.3 years for women. This study also indicated that a large proportion of the 
remaining years was spent in good health, and that this did not differ much between men and women 
[10]. These results have not been replicated so far.  
Multistate models facilitate a better understanding of transitions between health states and 
death among the oldest old. Recent developments in multistate modeling make it possible to study the 
role of risk factors, such as sex, in transitions between these states [11]. Moreover, based on multistate 
models, overall, healthy, and unhealthy life expectancies (LEs) may be estimated for specific groups 
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[12]. The objective of this study was to examine sex differences in total, healthy and unhealthy life 
expectancy in a population of nonagenarians (i.e., people aged 90 years and over). First, we investigate 
the role of sex in transitions between health states and death, using two different health indicators. 
Then, we estimate LEs for men and women to gain insight into the male-female health-survival 
paradox at very old age.  
 
2. Methods 
2.1 Study sample and design 
For this longitudinal study, data were used from the Vitality 90+ Study, a population-based study of 
nonagenarians in the city of Tampere, Finland [7, 9]. At baseline in 2001, all individuals aged 90 and 
older, irrespective of health or place of living, were included in a mailed survey. The data collection 
was repeated in 2003, 2007, 2010, and 2014, every time including the whole age group in the area. As 
all those who participated once were also included in the next waves, longitudinal data is available for 
all people who entered the study in 2001. At baseline, a questionnaire was mailed to all inhabitants 
aged 90 years and over (n = 1,129), of which 892 (79%) returned the questionnaire. The response rate 
was 86% among those still alive during the data collection, as 87 individuals had died between 
sampling and sending out of the questionnaires.  
In the current study, we included participants that returned the mailed questionnaire in 2001, 
and who had at least one health state at baseline (2001) and one health or death state at follow-up 
available (2003-2014). That was the case for 884 people, who provided a maximum of 2,501 
observations. The frequencies of number of observations were: two observations (n = 354), three 
observations (n = 399), four observations (n = 89) and five observations (n = 48). If persons were not 
able to fill out the questionnaire, they were instructed to ask help from a family member, caregiver, or 
friend. In certain cases, when participants were not able to select answers, these helpers participated as 
proxy. In this study, the percentage of proxy participants was 23.6%. Proxy rates were 15.3% for men 
and 25.6% for women (p difference <0.01). 
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The ethics committee of the Pirkanmaa Hospital District or the ethics committee of the 
Tampere Health Center, depending on the study year, approved the study. All participants or their 
legal representatives provided written informed consent. 
 
2.2 Measures 
Two health indicators were used in the current study, disability and multimorbidity, to see whether 
results were consistent across health indicators. Health indicators were identically measured at each 
follow-up. Disability was measured with five mobility activities and activities of daily living (ADL): 
to move about indoors, to walk 400 meters, to use stairs, to dress and undress and to get in and out of 
bed. For each item, identical questions were asked in the mailed questionnaire: “Are you able to..?”. 
Response categories were “Yes, without difficulty”, “Yes, with difficulty”, “Only if someone helps”, 
and “No”. Disability was defined as being dependent for two or more activities, where dependence 
was considered present if a participant was not able to perform a certain activity or only with help [13, 
14]. 
Morbidity was measured by self-report. Participants were asked in the mailed questionnaire 
whether a doctor had told them that they had any of the following ten conditions: hypertension, 
atherosclerosis, heart disease, cancer, dementia, stroke, diabetes, rheumatic disorder, osteoarthritis, 
and Parkinson`s disease. Multimorbidity was considered present if two or more diseases were reported 
[15].  
 
2.3 Mortality 
All-cause mortality status, including date of death, was retrieved from the Finnish National Population 
Register until May 2014, and linked to the dataset with personal identifier codes.  
 
2.4 Statistical analysis 
At baseline, characteristics of the study population were reported for the total sample and by sex, with 
means and standard deviation for continuous variables and percentages for categorical variables. 
Baseline differences between men and women were determined using Chi square tests and t-tests. 
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Multistate modeling was used to assess transitions between health states and death during 13 
years of follow-up. With multistate modeling it is possible to simultaneously model transitions 
between health states and to examine the role of covariates on all transitions. A three-state model was 
applied, where state 1 was the healthy state (absence of disability or multimorbidity), state 2 was the 
unhealthy state (disability or multimorbidity present), and state 3 was death as absorbing state (Figure 
1). Multistate survival models with age and sex as covariates were estimated separately for disability 
and multimorbidity. Age was included as time-varying covariate. Date of death was used to calculate 
the exact age of death. When participants had missing states between two known states, interval 
censoring was applied. Right censoring was applied when the last state was missing and the participant 
was known to be still alive. However, this was done for very few cases (n = 8), as most people had 
died at the end of the study period (May 2014). Initially, we allowed backward transitions from state 2 
to 1, but due to low numbers of backward transitions we had to fix this transition in the analyses on 
multimorbidity for both covariates, and we had to fix the sex parameter for this transition in the 
analyses on disability. Hazard ratios and 95% confidence intervals for state transitions are reported for 
age and sex.  
The multistate survival models were estimated using the MSM package for R [16]. Based on 
the parameters of the multistate models, LEs were calculated using the ELECT (Estimating Life 
Expectancies in Continuous Time) package for R [12]. ELECT estimates total and marginal LEs based 
on multinomial regression models for state prevalence. Total, unhealthy, and healthy LEs were 
estimated for men and women separately, for both disability and multimorbidity as health variables. 
LEs were estimated for individuals aged 90 to 100 years. To examine sex differences in total, 
unhealthy, and healthy life expectancy, 95% confidence intervals for LEs were estimated. All 
statistical analyses were performed using R version 3.4.2.  
 
3. Results  
Table 1 shows the characteristics at baseline for the total sample and by sex. The sample included 172 
men and 712 women. The mean age was 92.2 years (SD = 2.5), with a range from 90 to 106 years. In 
the total sample, multimorbidity prevalence at baseline was 67.3%, with heart disease (53.4%), 
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dementia (42.9%), osteoarthritis (35.8%), hypertension (31.8%) and atherosclerosis (16.7%) as the 
most common conditions. Multimorbidity was higher in women (70.6%) than in men (53.5%). 
Hypertension and osteoarthritis were more often present among women, whereas cancer was more 
frequently observed among men. Disability was present in 43.3% of the sample at baseline. All 
disability items showed a higher prevalence in women than in men (p<0.01).  
During 13 years of follow-up, 98.9% of the sample died (n=874). Among the 48 observations 
at the last follow-up measurement (in 2014), there were two valid health state observations, 8 were 
right-censored and 38 were death states (deceased between 2010 and 2014). The results of the 
multistate models are presented in Table 2. Age and sex were not associated with transitioning from a 
healthy state to an unhealthy state, for both health indicators. In the analyses using disability as health 
indicator, a higher age was associated with an increased risk of transitioning from a healthy state to 
death (HR = 1.15, 95% CI = 1.03-1.28) and with transitioning from an unhealthy state to death (HR = 
1.04, 95% CI = 1.02-1.07). Female sex was associated with a lower likelihood to transition from an 
unhealthy state to death (HR = 0.52, 95% CI = 0.40-0.67), but not with transitioning from a healthy 
state to death (HR = 0.52, 95% CI = 0.23-1.16). When using multimorbidity as health indicator, a 
higher age was again associated with a higher risk of transitioning from a healthy state to death (HR = 
1.14, 95% CI = 1.08-1.21) and from an unhealthy state to death (HR = 1.08, 95% CI = 1.06-1.11). For 
females, there was a lower risk of transitioning from a healthy state to death (HR = 0.51, 95% CI = 
0.31-0.84) and from an unhealthy state to death (HR = 0.73, 95% CI = 0.58-0.92). 
LEs were calculated for the ages 90 to 100 (Table 3 and Figure 2). The estimates for total life 
expectancy slightly differ between the two health indicators, due to small differences in the parameters 
and observations included in the analyses for each indicator. However, this does not affect the 
interpretation of results, as sex differences for total life expectancy are consistent across health 
indicators. Total life expectancy at age 90 was around 3.7 years for women and 3 years for men, 
corresponding with a difference of 8 months in total life expectancy. This decreased to 1.8 years 
(women) and 1.3 years (men) at the age of 100, which is still a difference of 6 months in total life 
expectancy.  
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For both health indicators, sex differences in unhealthy life expectancy were observed, 
showing that women spend more time in poor health, in both absolute (years) and relative (proportion) 
terms. The average life expectancy with disability for women was 2 years at age 90, 1.7 years at age 
95 and 1.5 years at age 100, which corresponds to 53%, 66%, and 78% of the total life expectancy, 
respectively. For men, life expectancy with disability at the age of 90, 95 and 100 was 26%, 36% and 
48% of total life expectancy, respectively. Figure 2 provides an illustration of these differences. 
Similar patterns were observed for life expectancy with multimorbidity, although sex differences were 
a bit smaller when using this health indicator. Table 3 also provides healthy life expectancy estimates. 
Between the age of 90 and 95, men had higher disability-free life expectancy than women. For 
example, at the age of 90 the sex difference in disability-free life expectancy was 6 months, in favor of 
men. At the age of 100, sex differences in disability-free life expectancy were no longer observed. For 
multimorbidity, no sex differences in healthy life expectancy were found. 
 
4. Discussion 
The main aim of this study was to examine sex differences in total, healthy, and unhealthy life 
expectancy among nonagenarians, using estimates based on multistate survival models. The results 
indicated that sex differences in LEs were present up to very high age. Differences were mainly 
observed in total and unhealthy life expectancy: women aged 90 years and over live longer than men, 
and spend more time in poor health, for both disability and multimorbidity as health indicator. Based 
on these results we conclude that the male-female health-survival paradox is still present in the very 
old.  
The results of this study revealed that the total life expectancy at the age of 90 was 3.7 years 
for women and 3 years for men. This is not very different from a previous study in a Danish 
population, that found an average lifetime among nonagenarians of 3.3 years for women and 2.7 years 
for men [10]. However, this study only provided averages for the total group aged 90 and over, and 
did not calculate LEs for specific ages. Our findings provide a more detailed insight into decreases in 
life expectancy with advancing age. For a person aged 100 years, the total life expectancy decreased to 
1.8 years for women and 1.3 years for men.  
9 
 
Patterns with regard to unhealthy life expectancy were similar to those previously observed in 
younger age groups [1], as we found that women live more years with disability and multimorbidity 
than men. At the age of 90, women spend on average 14 months more with disability and 12 months 
more with multimorbidity than men. A large proportion of the total life expectancy between the ages 
of 90 and 100 is estimated to be in the unhealthy state. These findings are contrary to those from the 
previously mentioned study in Denmark, where nonagenarians were estimated to spend 75% of their 
remaining lifetime in physical independence. Moreover, this Danish study did not find substantial sex 
differences in unhealthy life expectancy. This suggests that estimates should be interpreted in the 
context of the country where the research is conducted. With regard to healthy life expectancy, we 
observed between the age of 90 and 95 that men had a higher disability-free life expectancy of about 5 
to 6 months. This is line with results from the Newcastle 85+ study, in which men were estimated to 
live 6 months longer without disability compared to women [8]. 
Women were less likely to transition from a healthy or unhealthy state to death than men. This 
is probably just an expression of the lower mortality rates among female nonagenarians [9]. The 
finding that age and sex were not associated with transitioning from a healthy state to an unhealthy 
state in the multistate models, may be due to the fact that prevalence of disability and multimorbidity 
was already high at baseline. It is known that among nonagenarians the prevalence of disability and 
multimorbidity is high [17, 18].  
This was one of the first studies to use longitudinal data to estimate LEs in the oldest old. 
Strengths of the study include the large sample of nonagenarians, the use of an entire age cohort from 
one area, the long follow-up period, and the novel analytical approach. The multistate survival model 
approach is among the few statistical methods that does not require national life table data to calculate 
LEs [12, 19], as opposed to the commonly used Sullivan method [20]. Using the ELECT package in 
R, LEs may be calculated in any longitudinal dataset with information on health states and mortality. 
Nevertheless, some limitations should be considered when interpreting the results of this study. First, 
the number of men included in this study is small as compared to the number of women. However, this 
reflects that mortality rates are higher among men. The percentage of men corresponds with their share 
in the total population. In the Vitality 90+ study, there were no differences in participation rates 
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between men and women [9]. Second, it is possible that mortality rates among nonagenarians have 
declined in recent years. These possible cohort effects were not considered in this study, and should be 
addressed in future research. Finally, most measures included in our analyses – except mortality - were 
based on self-report. It is well-known that self-reported data may lead to bias. The same may be true 
for reporting by proxy. However, previous research with data from the Vitality 90+ study indicated 
that for disability and disease proxy answers are sufficiently reliable [9, 21].  
There are several potential explanations for our findings that should be addressed in future 
research. First, there may be sex differences in self-reporting or proxy-reporting of disease and 
disability, that may explain higher rates of poor health among women. Second, various explanatory 
factors could be considered in the analyses, such as life course experiences prior to age 90 and living 
arrangements. For example, among nonagenarians women are more likely than men to be widow or to 
live alone. Finally, more research could be devoted to biological differences between men and women, 
in order to explain sex differences in longevity.  
The increasing number of oldest old in the population is a major challenge for healthcare 
systems, as the prevalence of diseases and disability among nonagenarians is very high [18]. Yet, 
much more research in the oldest old is needed to better understand why women live longer with 
multimorbidity and disability than men, even in this selective group at very old age. The field would 
also benefit from comparative research in multiple countries [22], to see whether life expectancy 
patterns in nonagenarians are consistent across countries. Most studies among the oldest old have been 
conducted in one country or setting [23, 24], and it is likely that LEs in the oldest old reflect the 
specific conditions in each of these countries and settings. Finally, other health indicators than 
disability and multimorbidity may be considered in future life expectancy research, for example 
physical performance measures and risk indicators such as frailty [25-27]. Ultimately, findings from 
these studies may be used to inform public health policy, and to develop interventions focused on 
maintaining independence among the oldest old. For example, the high prevalence of mobility 
disability in the current study sample would call for interventions focused on mobility and physical 
activity [28].  
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In conclusion, this longitudinal study showed that sex differences in total and unhealthy life 
expectancy were present in a sample of people aged 90 and over. Therefore, the results provide 
support for the male-female health-survival paradox at very old age. Women aged 90+ live longer than 
men, and spend more time in poor health.  
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Table 1. Baseline characteristics of the study population 
 
 Total Men Women p* 
 n = 884 n = 172 n = 712   
Age, mean (SD) 92.2 (2.5) 91.9 (2.3) 92.3 (2.6) 0.11 
Multimorbidity, % 2 or more diseases 67.3 53.5 70.6 <0.001 
    Hypertension, % 31.8 18.2 35.1 <0.001 
    Atherosclerosis, % 16.7 19.4 16.1 0.29 
    Heart disease, % 53.4 49.4 54.4 0.24 
    Cancer, % 11.0 16.5 9.7 <0.05 
    Dementia, % 42.9 38.8 43.9 0.23 
    Stroke, % 7.9 6.5 8.2 0.44 
    Diabetes, % 10.9 7.6 11.6 0.13 
    Rheumatic disorder, % 8.5 7.1 8.1 0.46 
    Osteoarthritis, % 35.8 25.9 38.2 <0.01 
    Parkinson`s disease, % 2.4 1.2 2.7 0.25 
Disability, % dependence for 2 or more mobility or 
ADL activities  
43.3 27.9 47.0 <0.001 
    To move about indoors, % dependence 19.5 11.7 21.4 <0.01 
    To walk 400 meters, % dependence 49.5 33.5 53.8 <0.001 
    To use stairs, % dependence 49.3 33.5 53.1 <0.001 
    To dress and undress, % dependence 28.3 19.8 30.4 <0.01 
    To get in and out of bed, % dependence 19.5 10.5 21.7 <0.01 
Respondent      
    Participant, % 76.4 84.7 74.4 <0.01 
    Proxy, % 23.6 15.3 25.6  
  
* t-test or chi-square test 
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Figure 1. Design: three-state model  
 
1. Healthy 
(no disability or no 
multimorbidity)
2. Unhealthy 
(disability or 
multimorbidity)
3. Death
 
 
 
 
 
 
 
 
Table 2. Hazard ratios and 95% confidence intervals for the effect of age and sex on transitions 
through the different health states 
 
 Disability Multimorbidity 
 Age Sex Age Sex 
Transitions HR  (95% CI) HR  (95% CI) HR  (95% CI) HR  (95% CI) 
State 1 –State 2 1.07 (0.99, 1.14) 1.37 (0.82, 2.27) 0.97 (0.91, 1.04) 1.61 (0.97, 2.70) 
State 1 - Death 1.15 (1.03, 1.28)* 0.52 (0.23, 1.16) 1.14 (1.08, 1.21)* 0.51 (0.31, 0.84)* 
State 2 – State 1 0.89 (0.74, 1.08) -- --                           -- 
State 2 - Death 1.04 (1.02, 1.07)* 0.52 (0.40, 0.67)* 1.08 (1.06, 1.11)* 0.73 (0.58, 0.92)* 
 
State 1 = healthy (no disability or no multimorbidity); State 2 = unhealthy (disability or 
multimorbidity); Sex (0 = men, 1 = women); *p<0.05; N observations disability = 2,501; N 
observations multimorbidity = 2,488 
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Table 3. Life expectancy estimates for men and women by health indicator 
 
  Disability Multimorbidity 
  Men Women  Men Women 
Age 90 Total life expectancy in years (95% CIs) 3.13 (2.68, 3.51) 3.77 (3.53, 3.99)*  2.96 (2.60, 3.34) 3.70 (3.46, 3.92)* 
 Unhealthy life expectancy in years (95% CIs) 0.84 (0.64, 1.06) 2.01 (1.81, 2.18)* 1.68 (1.41, 1.98) 2.66 (2.46, 2.85)* 
 Healthy life expectancy in years (95% CIs) 2.28 (1.84, 2.66) 1.76 (1.58, 1.95)* 1.28 (0.99, 1.26) 1.04 (0.89, 1.19) 
Age 95 Total life expectancy in years (95% CIs) 2.01 (1.57, 2.30) 2.64 (2.42, 2.91)* 1.98 (1.69, 2.28) 2.62 (2.41, 2.83)* 
 Unhealthy life expectancy in years (95% CIs) 0.72 (0.52, 0.92) 1.74 (1.54, 1.94)* 1.05 (0.86, 1.27) 1.78 (1.60, 1.96)* 
 Healthy life expectancy in years (95% CIs) 1.29 (0.96, 1.54) 0.91 (0.76, 1.08)* 0.93 (0.72, 1.17) 0.85 (0.69, 1.00) 
Age 100 Total life expectancy in years (95% CIs) 1.27 (0.87, 1.56) 1.91 (1.63, 2.22)* 1.25 (0.98, 1.59) 1.78 (1.55, 2.05)* 
 Unhealthy life expectancy in years (95% CIs) 0.62 (0.44, 0.83) 1.49 (1.22, 1.78)* 0.63 (0.47, 0.85) 1.14 (0.95, 1.38)* 
 Healthy life expectancy in years (95% CIs) 0.64 (0.34, 0.89) 0.42 (0.29, 0.59) 0.62 (0.39, 0.90) 0.64 (0.47, 0.84) 
 
*Sex difference = p <0.05 
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Figure 2. Life expectancy in good and poor health by gender and health indicator (in years) 
 
 
 
 
 
 
